Durski Kara N, McCollum Andrea M, Nakazawa Yoshinori, Petersen Brett W, Reynolds Mary G, Briand Sylvie, Djingarey Mamoudou Harouna, Olson Victoria, Damon Inger K, Khalakdina Asheena
MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):306-310. doi: 10.15585/mmwr.mm6710a5.
The recent apparent increase in human monkeypox cases across a wide geographic area, the potential for further spread, and the lack of reliable surveillance have raised the level of concern for this emerging zoonosis. In November 2017, the World Health Organization (WHO), in collaboration with CDC, hosted an informal consultation on monkeypox with researchers, global health partners, ministries of health, and orthopoxvirus experts to review and discuss human monkeypox in African countries where cases have been recently detected and also identify components of surveillance and response that need improvement. Endemic human monkeypox has been reported from more countries in the past decade than during the previous 40 years. Since 2016, confirmed cases of monkeypox have occurred in Central African Republic, Democratic Republic of the Congo, Liberia, Nigeria, Republic of the Congo, and Sierra Leone and in captive chimpanzees in Cameroon. Many countries with endemic monkeypox lack recent experience and specific knowledge about the disease to detect cases, treat patients, and prevent further spread of the virus. Specific improvements in surveillance capacity, laboratory diagnostics, and infection control measures are needed to launch an efficient response. Further, gaps in knowledge about the epidemiology and ecology of the virus need to be addressed to design, recommend, and implement needed prevention and control measures.
近期,人类猴痘病例在广泛的地理区域内明显增加,且有进一步传播的可能性,同时缺乏可靠的监测,这些情况都增加了人们对这种新出现的人畜共患病的担忧程度。2017年11月,世界卫生组织(WHO)与美国疾病控制与预防中心(CDC)合作,就猴痘问题与研究人员、全球卫生伙伴、各国卫生部以及正痘病毒专家举行了一次非正式磋商会,以审查和讨论在近期发现病例的非洲国家中的人类猴痘情况,并确定需要改进的监测和应对措施的组成部分。在过去十年中,报告出现地方性人类猴痘的国家比此前40年中的更多。自2016年以来,中非共和国、刚果民主共和国、利比里亚、尼日利亚、刚果共和国、塞拉利昂以及喀麦隆的圈养黑猩猩中均出现了猴痘确诊病例。许多有地方性猴痘的国家缺乏近期关于该疾病的经验和专门知识,难以发现病例、治疗患者以及防止病毒进一步传播。需要在监测能力、实验室诊断和感染控制措施方面进行具体改进,以展开有效的应对。此外,需要填补有关该病毒流行病学和生态学知识方面的空白,以便设计、推荐和实施所需的预防和控制措施。